Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Broadcom
AVGO
|
+$406M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$351M |
| 3 |
Meta Platforms (Facebook)
META
|
+$316M |
| 4 |
Walmart
WMT
|
+$230M |
| 5 |
ServiceNow
NOW
|
+$217M |
Top Sells
| 1 |
Apple
AAPL
|
+$549M |
| 2 |
Palantir
PLTR
|
+$549M |
| 3 |
Netflix
NFLX
|
+$378M |
| 4 |
NVIDIA
NVDA
|
+$267M |
| 5 |
Alibaba
BABA
|
+$207M |
Sector Composition
| 1 | Technology | 17.41% |
| 2 | Healthcare | 14.96% |
| 3 | Consumer Discretionary | 11.86% |
| 4 | Financials | 11.03% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Deutsche Bank
DB
$71.4B
| $299K | ﹤0.01% |
+12,722
| New | +$299K |
|
2927
TELA Bio
TELA
$64.2M
| $298K | ﹤0.01% |
244,444
-180,696
| -43% | -$220K |
|
2928
Data Storage Corp
DTST
$33.1M
| $297K | ﹤0.01% |
81,900
-1,200
| -1% | -$4.36K |
|
2929
Iterum Therapeutics
ITRM
$31.7M
| $296K | ﹤0.01% |
240,900
-197,916
| -45% | -$243K |
|
2930
Morgan Stanley Direct Lending Fund
MSDL
$1.55B
| $295K | ﹤0.01% |
14,764
-337,936
| -96% | -$6.75M |
|
2931
Repare Therapeutics
RPTX
$77.8M
| $294K | ﹤0.01% |
298,661
-48,799
| -14% | -$48.1K |
|
2932
MEI Pharma
MEIP
$101M
| $294K | ﹤0.01% |
134,446
-500
| -0.4% | -$1.1K |
|
2933
Educational Development Corp
EDUC
$9.36M
| $294K | ﹤0.01% |
214,845
-7,700
| -3% | -$10.5K |
|
2934
Bridgeline Digital
BLIN
$16.1M
| $294K | ﹤0.01% |
198,529
+67,625
| +52% | +$100K |
|
2935
Century Casinos
CNTY
$76.3M
| $293K | ﹤0.01% |
173,149
+2,200
| +1% | +$3.72K |
|
2936
Rapid Micro Biosystems
RPID
$130M
| $292K | ﹤0.01% |
110,587
-72,500
| -40% | -$191K |
|
2937
Bogota Financial
BSBK
$116M
| $290K | ﹤0.01% |
37,851
| – | – |
|
2938
Mersana Therapeutics
MRSN
$37.3M
| $289K | ﹤0.01% |
33,597
+9,346
| +39% | +$80.4K |
|
2939
Comscore
SCOR
$32.2M
| $289K | ﹤0.01% |
42,021
-3,415
| -8% | -$23.5K |
|
2940
Heartland Express
HTLD
$671M
| $284K | ﹤0.01% |
+30,800
| New | +$284K |
|
2941
Vanguard Materials ETF
VAW
$2.92B
| $283K | ﹤0.01% |
1,500
-2,300
| -61% | -$434K |
|
|
ACCS
2942
ACCESS Newswire Inc.
ACCS
$41.4M
| $283K | ﹤0.01% |
32,038
-3,700
| -10% | -$32.7K |
|
2943
Acumen Pharmaceuticals
ABOS
$84.2M
| $282K | ﹤0.01% |
256,700
-513
| -0.2% | -$564 |
|
2944
The Oncology Institute
TOI
$296M
| $282K | ﹤0.01% |
247,600
+65,600
| +36% | +$74.8K |
|
2945
iShares Select Dividend ETF
DVY
$20.9B
| $282K | ﹤0.01% |
+2,100
| New | +$282K |
|
2946
YieldMax Ultra Option Income Strategy ETF
ULTY
$3.14B
| $281K | ﹤0.01% |
46,500
-11,950
| -20% | -$72.3K |
|
2947
Zenvia
ZENV
$69.7M
| $281K | ﹤0.01% |
133,201
+32,800
| +33% | +$69.2K |
|
2948
GrowGeneration
GRWG
$92.6M
| $281K | ﹤0.01% |
260,186
+5,076
| +2% | +$5.48K |
|
2949
Ark Restaurants
ARKR
$25.3M
| $279K | ﹤0.01% |
27,611
-200
| -0.7% | -$2.02K |
|
2950
Coca-Cola
KO
$291B
| $278K | ﹤0.01% |
3,898
-1,115
| -22% | -$79.6K |
|